Intelligent Viral Infection Treatment Systems
Legal Citation
Summary of the Inventive Concept
This invention integrates pharmaceutical compositions comprising substituted nucleotides and nucleosides with advanced technologies such as artificial intelligence, blockchain, IoT, and nanomaterials to create a more effective and personalized treatment system for viral infections.
Background and Problem Solved
The original patent disclosed pharmaceutical compositions for treating viral infections, but it lacked the integration of modern technologies to enhance treatment outcomes. This inventive concept addresses the limitations of the original patent by combining the compositions with AI-powered diagnostic tools, blockchain-based tracking systems, IoT sensors, and nanomaterial-based delivery systems to provide more targeted and efficient treatment.
Detailed Description of the Inventive Concept
The system comprises a pharmaceutical composition of claim 1, integrated with an AI-powered diagnostic tool that analyzes patient data and recommends optimal dosage and administration schedules. The system also incorporates a blockchain-based tracking system to ensure authenticity and integrity of the composition throughout the supply chain, and utilizes IoT sensors to monitor storage conditions and detect potential contamination. Furthermore, the system includes a nanomaterial-based delivery system designed to target specific cells or tissues and enhance the bioavailability of the composition.
Novelty and Inventive Step
The new claims introduce the novel integration of AI, blockchain, IoT, and nanomaterials with the pharmaceutical compositions, providing a synergistic combination that enhances treatment outcomes and addresses the limitations of the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the system may include the use of different AI algorithms, blockchain platforms, or IoT devices. Variations may also include the integration of additional technologies, such as machine learning or robotics, to further enhance the treatment system.
Potential Commercial Applications and Market
The intelligent viral infection treatment system has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine and precision healthcare.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical biotechnology, specifically viral infection treatment compositions and advanced medical technology integration, requiring advanced degrees in pharmaceutical sciences, biotechnology, or related engineering disciplines with expertise in drug delivery systems, AI applications in healthcare, and nanomaterial design
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with advanced technical knowledge in pharmaceutical composition design, biotechnology, AI/machine learning, blockchain technologies, and IoT sensor systems, capable of interdisciplinary problem-solving and technological integration
Obviousness Rationale
A PHOSITA would recognize that integrating advanced technologies with pharmaceutical compositions represents a predictable solution for enhancing treatment efficacy, monitoring, and personalization. The source patent's nucleotide composition provides a foundational technology that naturally invites technological augmentation through known digital and nanoscale approaches. The proposed variations represent logical extensions of existing technological capabilities in precision medicine and drug delivery systems.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,560 |
|---|---|
| Title | Pharmaceutical compositions comprising substituted nucleotides and nucleosides for treating viral infections |
| Assignee(s) | Emory University |